Related Experiment Videos
Endogenous brain protection: models, gene expression, and mechanisms.
1High-Throughput Biology, Discovery Research, GlaxoSmithKline Pharmaceuticals, King of Prussia, PA, USA.
Methods in Molecular Medicine
|September 30, 2004
Summary
Brief exposure to injury (ischemic preconditioning) protects the brain from subsequent, longer injury (ischemic tolerance). Understanding these neuroprotective mechanisms may reveal new stroke and CNS injury treatments.
Area of Science:
- Neuroscience
- Cellular Biology
- Pathology
Background:
- Endogenous protective mechanisms activate in response to sub-injurious stimuli.
- Ischemic preconditioning (PC) confers tolerance to subsequent prolonged ischemia (IT).
- PC/IT has been observed in the human brain.
Purpose of the Study:
- To overview PC/IT research.
- To illustrate data generation from in vivo and in vitro models for understanding neuroprotection.
- To emphasize the importance of future research for discovering new therapeutic targets.
Main Methods:
- Review of existing PC/IT research.
- Analysis of gene and protein expression data from experimental models.
- In vivo and in vitro experimental approaches.
Main Results:
- PC/IT demonstrates significant neuroprotective effects against ischemic injury.
- Experimental models yield data on gene and protein expression linked to neuroprotection.
- PC/IT mechanisms are conserved across species, including humans.
Conclusions:
- Understanding PC/IT is crucial for developing novel treatments for stroke and CNS injuries.
- Further research into PC/IT mechanisms can identify new therapeutic targets.
- PC/IT represents a promising endogenous defense against brain injury.